반응식
C(OC([N:8]1[CH2:21][CH2:20][N:19]2[CH:10]([C:11](=[O:36])[NH:12][C:13]3[C:18]2=[N:17][CH:16]=[C:15]([CH2:22][N:23]2[CH2:28][CH2:27][N:26]([C:29]4[CH:34]=[CH:33][C:32]([Cl:35])=[CH:31][CH:30]=4)[CH2:25][CH2:24]2)[CH:14]=3)[CH2:9]1)=O)(C)(C)C.FC(F)(F)C(O)=O>ClCCl>[Cl:35][C:32]1[CH:33]=[CH:34][C:29]([N:26]2[CH2:25][CH2:24][N:23]([CH2:22][C:15]3[CH:14]=[C:13]4[C:18]([N:19]5[CH:10]([C:11](=[O:36])[NH:12]4)[CH2:9][NH:8][CH2:21][CH2:20]5)=[N:17][CH:16]=3)[CH2:28][CH2:27]2)=[CH:30][CH:31]=1참가 물질
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
7-[4-(4-Chloro-phenyl)-piperazin-1-ylmethyl]-10-oxo-1,3,4,9,10,10a-hexahydro-2,4a,5,9-tetraaza-phenanthrene-2-carboxylic acid tert-butyl ester (250 mg, 0.487 mmol) was dissolved in dichloromethane (5 mL) and trifluoroacetic acid (3 mL) was added while stirring at room temperature. The reaction was stirred for 16 h and concentrated to a residue. The residue was dissolved in DMF and purified via HPLC (55-90% acetonitrile in water, ammonium bicarbonate buffer). The fractions were combined and concentrated until a white solid precipitated. The precipitate was filtered off and dried in vacuum to afford the title compound (17.8 mg, 8.8%) as a white solid. 1H NMR (DMSO-d6) δ (ppm): 10.68 (s, 1H), 7.70 (d, J=2.0 Hz, 1H), 7.14-7.30 (m, 2H), 7.03 (d, J=2.0 Hz, 1H), 6.92 (d, J=9.1 Hz, 2H), 4.33 (d, J=11.4 Hz, 1H), 3.97 (dd, J=11.0, 3.4 Hz, 1H), 3.45 (dd, J=12.5, 2.9 Hz, 4H), 3.32-3.36 (m, 4H), 3.16 (d, J=9.6 Hz, 1H), 3.06-3.13 (m, 4H), 2.72-2.87 (m, 3H). [M+H] calc'd for C26H33ClN6O3, 413; found, 413.
후처리
- stirringThe reaction was stirred for 16 h
- concentrationconcentrated to a residue
- dissolutionThe residue was dissolved in DMF
- custompurified via HPLC (55-90% acetonitrile in water, ammonium bicarbonate buffer)
- concentrationconcentrated until a white solid
- customprecipitated
- filtrationThe precipitate was filtered off
- customdried in vacuum
출처 및 근거
- ORD 기록
- ord-b090dd42b629492e94a51bd9a8048200
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08822470B2
연결된 노트
불러오는 중…